The company has been awarded for supply of 5.99 million doses of EasyfiveTT (DTP-HepB-Hib) fully liquid pentavalent vaccine for calendar year 2015 and 2016
Panacea Biotec, among the largest producer of vaccines and a research based pharmaceutical and biotechnology company has been elected for supply of Pentavalent Vaccine DTP-HepB-Hib by Pan American Health Organization (PAHO). The company has been awarded for supply of 5.99 million doses of EasyfiveTT (DTP-HepB-Hib) fully liquid pentavalent vaccine for calendar year 2015 and 2016 worth $13.49 million (equivalent to around Rs.83.52 crores) to meet the requirements of global immunisation programme.
Commenting on the development Dr Rajesh Jain, Joint Managing Director, Panacea Biotec said, “We are pleased with this opportunity of supplying Easyfive-TT vaccines to meet the requirements of PAHO once again after a gap of three years. Panacea Biotec has been playing a leadership role in the vaccines R&D, manufacturing and supply to meet demands of national and international agencies of good quality affordable vaccines for the developing world.”
Comments are closed.